Skip to menu Skip to content Skip to footer
Dr Matthew Roberts
Dr

Matthew Roberts

Email: 
Phone: 
+61 7 334 66047

Overview

Background

Matthew J. Roberts, BSc, MBBS, PhD, FRACS (Urol)

  • Consultant Urologist, Royal Brisbane and Women’s (RBWH), Surgical Treatment and Rehabilitation Service (STARS), Queensland Health
  • Clinician Research Fellow, Metro North Hospital and Health Service
  • Group Leader & Associate Professor, The University of Queensland Centre for Clinical Research

Matthew is a medical graduate of The University of Queensland and completed Urology specialty training in Queensland and New South Wales. He completed his PhD under the supervision of Professor “Frank” Gardiner investigating new biomarkers for the early detection and characterization of prostate cancer.

Matthew is a surgeon-scientist, working clinically as a urologist and robotic surgeon at RBWH & STARS with academic appointment as Clinician Research Fellow at Metro North Health (Qld) and Associate Professor at UQCCR. His clinical and research interests are in Urologic cancers (e.g. prostate cancer), focusing on novel imaging and biomarkers, clinical trials, urological infections and innovation in urology. He has authored over 140 peer reviewed manuscripts in international journals and presented research at more than 20 international urology and clinical cancer meetings. He is a member of the EAU Prostate Cancer Guidelines Committee, Prostate Cancer Outcomes Registry (PCOR)-Queensland Steering Committee, Editorial Board of the BJU International, as well as Co-Convenor of the ANZUP 2024 ASM.

Availability

Dr Matthew Roberts is:
Available for supervision

Qualifications

  • Bachelor of Biomedical Science, The University of Queensland
  • Bachelor of Medicine, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Research interests

  • Urology

    All fields related to urology including urologic oncology, prostate cancer, kidney/renal cancer, bladder cancer and others. Urologic infections Quality-of-life and survivorship research Systematic review and meta-analysis.

Works

Search Professor Matthew Roberts’s works on UQ eSpace

263 works between 2000 and 2025

101 - 120 of 263 works

2022

Journal Article

Painless penile periurethral polymicrobial abscess causing urinary retention

Tariq, Arsalan, Stewart, Adam G., Teloken, Patrick E., Dunglison, Nigel T., Martin, Benjamin F. and Roberts, Matthew J. (2022). Painless penile periurethral polymicrobial abscess causing urinary retention. Urology Case Reports, 42 102037, 1-3. doi: 10.1016/j.eucr.2022.102037

Painless penile periurethral polymicrobial abscess causing urinary retention

2022

Journal Article

Pituitary metastasis of renal cell carcinoma characterized by 18F-prostate-specific membrane antigen-1007 PET/CT

Tariq, Arsalan, Raman, Vignesh, Alexander, Hamish, Roberts, Matthew J. and Thomas, Paul (2022). Pituitary metastasis of renal cell carcinoma characterized by 18F-prostate-specific membrane antigen-1007 PET/CT. Clinical Nuclear Medicine, 47 (4), E346-E347. doi: 10.1097/RLU.0000000000004055

Pituitary metastasis of renal cell carcinoma characterized by 18F-prostate-specific membrane antigen-1007 PET/CT

2022

Journal Article

High PSMA PET SUVmax in PI‐RADS 4 or 5 men confers a high probability of significant prostate cancer

Ptasznik, Gideon, Papa, Nathan, Kelly, Brian D., Thompson, James, Stricker, Phillip, Roberts, Matthew J., Hofman, Michael, Buteau, James, Murphy, Declan G., Emmett, Louise and Moon, Daniel (2022). High PSMA PET SUVmax in PI‐RADS 4 or 5 men confers a high probability of significant prostate cancer. BJU International, 130 (S3), 5-7. doi: 10.1111/bju.15736

High PSMA PET SUVmax in PI‐RADS 4 or 5 men confers a high probability of significant prostate cancer

2022

Journal Article

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

Roberts, Matthew J., Morton, Andrew, Papa, Nathan, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Coughlin, Geoffrey, Gianduzzo, Troy, Kua, Boon, McEwan, Louise, Wong, David, Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Brown, Nicholas, Parkinson, Robert, Emmett, Louise and Yaxley, John W. (2022). Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging, 49 (9), 3289-3294. doi: 10.1007/s00259-022-05756-2

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

2022

Journal Article

Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer

Raveenthiran, S., Yaxley, W. J., Franklin, T., Coughlin, G., Roberts, M., Gianduzzo, T., Kua, B., Samaratunga, H., Delahunt, B., Egevad, L., Wong, D., McEwan, L., Brown, N., Parkinson, R., Esler, R. and Yaxley, J. W. (2022). Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer. Journal of Urology, 207 (3), 573-580. doi: 10.1097/JU.0000000000002293

Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer

2022

Journal Article

Optimizing combined Magnetic Resonance Imaging (MRI)-targeted and systematic biopsy strategies: sparing the multiparametric MRI-negative transitional zone in presence of exclusively peripheral multiparametric MRI-suspect lesions

Kachanov, Mykyta, Leyh-Bannurah, Sami-Ramzi, Roberts, Matthew J., Sauer, Markus, Beyersdorff, Dirk, Boiko, Svitlana, Maurer, Tobias, Steuber, Thomas, Graefen, Markus and Budaus, Lars (2022). Optimizing combined Magnetic Resonance Imaging (MRI)-targeted and systematic biopsy strategies: sparing the multiparametric MRI-negative transitional zone in presence of exclusively peripheral multiparametric MRI-suspect lesions. Journal of Urology, 207 (2), 333-340. doi: 10.1097/JU.0000000000002248

Optimizing combined Magnetic Resonance Imaging (MRI)-targeted and systematic biopsy strategies: sparing the multiparametric MRI-negative transitional zone in presence of exclusively peripheral multiparametric MRI-suspect lesions

2022

Journal Article

The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison

Tariq, Arsalan, Kwok, Michael, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Marsh, Phillip, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Westera, Jurjen, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2022). The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison. Urologic Oncology: Seminars and Original Investigations, 40 (2) 66.e1, 66.e1-66.e9. doi: 10.1016/j.urolonc.2021.11.006

The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison

2022

Journal Article

EDITORIAL COMMENT

Roberts, Matthew J. and Emmett, Louise (2022). EDITORIAL COMMENT. Journal of Urology, 207 (2), 348-349. doi: 10.1097/JU.0000000000002254.01

EDITORIAL COMMENT

2022

Journal Article

Determining risk factors for symptomatic urinary tract infection following trial of void: A retrospective analysis

Kwok, Michael, Yaxley, William, Ranasinghe, Sachinka, Morton, Leanne, Perera, Sachin, Ponen, Kreyen, Pelecanos, Anita, Britton, Sumudu, Harris, Patrick N. A., Paterson, David L., Esler, Rachel, Hussey, David, Yaxley, John W. and Roberts, Matthew J. (2022). Determining risk factors for symptomatic urinary tract infection following trial of void: A retrospective analysis. Journal of Clinical Urology, 17 (6), 205141582210998-587. doi: 10.1177/20514158221099856

Determining risk factors for symptomatic urinary tract infection following trial of void: A retrospective analysis

2022

Journal Article

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

Nepogodiev, Dmitri, Simoes, Joana FF, Li, Elizabeth, Picciochi, Maria, Glasbey, James C, Baiocchi, Glauco, Blanco-Colino, Ruth, Chaudhry, Daoud, AlAmeer, Ehab, El-Boghdadly, Kariem, Wuraola, Funmilola, Ghosh, Dhruva, Gujjuri, Rohan R, Harrison, Ewen M, Lule, Herman, Kaafarani, Haytham, Khosravi, Mohammad, Kronberger, Irmgard, Leventoglu, Sezai, Mann, Harvinder, Mclean, Kenneth A, Mengesha, Mengistu Gebreyohanes, Modolo, Maria Marta, Ntirenganya, Faustin, Norman, Lisa, Outani, Oumaima, Pius, Riinu, Pockney, Peter, Qureshi, Ahmad Uzair ... Mutambanengwe, Precious G T (2022). SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia, 77 (1), 28-39. doi: 10.1111/anae.15563

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

2022

Journal Article

Lymph node classification in E-PSMA reporting guidelines for PSMA-PET

Arnfield, Evyn G., Roberts, Matthew J. and Pattison, David A. (2022). Lymph node classification in E-PSMA reporting guidelines for PSMA-PET. European Journal of Nuclear Medicine and Molecular Imaging, 50 (1), 1-2. doi: 10.1007/s00259-022-05943-1

Lymph node classification in E-PSMA reporting guidelines for PSMA-PET

2021

Journal Article

Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

Chikatamarla, Venkata Avinash, Okano, Satomi, Jenvey, Peter, Ansaldo, Alexander, Roberts, Matthew J., Ramsay, Stuart C., Thomas, Paul A. and Pattison, David A. (2021). Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging. EJNMMI Research, 11 (1) 128, 128. doi: 10.1186/s13550-021-00869-5

Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

2021

Journal Article

The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study

Emmett, Louise, Buteau, James, Papa, Nathan, Moon, Daniel, Thompson, James, Roberts, Matthew J., Rasiah, Kris, Pattison, David A., Yaxley, John, Thomas, Paul, Hutton, Anthony C., Agrawal, Shikha, Amin, Amer, Blazevski, Alexandar, Chalasani, Venu, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Sheehan-Dare, Gemma, Kooner, Raji, Coughlin, Geoff, Chan, Lyn, Cusick, Thomas, Namdarian, Benjamin, Kapoor, Jada, Alghazo, Omar, Woo, Henry H., Lawrentschuk, Nathan ... Stricker, Phillip (2021). The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study. European Urology, 80 (6), 682-689. doi: 10.1016/j.eururo.2021.08.002

The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study

2021

Journal Article

Extra‐peritoneal oligometastatic renal cell carcinoma: atypical pattern of metastasis and novel localization techniques

Tariq, Arsalan, Westera, Jurjen, Navaratnam, Anojan, Dunglison, Nigel, Esler, Rachel and Roberts, Matthew J. (2021). Extra‐peritoneal oligometastatic renal cell carcinoma: atypical pattern of metastasis and novel localization techniques. ANZ Journal of Surgery, 92 (6), 1553-1555. doi: 10.1111/ans.17335

Extra‐peritoneal oligometastatic renal cell carcinoma: atypical pattern of metastasis and novel localization techniques

2021

Journal Article

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

Glasbey, James, Ademuyiwa, Adesoji, Adisa, Adewale, Alameer, Ehab, Arnaud, Alexis P, Ayasra, Faris, Azevedo, José, Minaya-Bravo, Ana, Costas-Chavarri, Ainhoa, Edwards, John, Elhadi, Muhammed, Fiore, Marco, Fotopoulou, Christina, Gallo, Gaetano, Ghosh, Dhruva, Griffiths, Ewen A, Harrison, Ewen, Hutchinson, Peter, Lawani, Ismail, Lawday, Samuel, Lederhuber, Hans, Leventoglu, Sezai, Li, Elizabeth, Gomes, Gustavo Mendonça Ataíde, Mann, Harvinder, Marson, Ella J, Martin, Janet, Mazingi, Dennis, McLean, Kenneth ... Aldawbali, M. (2021). Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. The Lancet Oncology, 22 (11), 1507-1517. doi: 10.1016/S1470-2045(21)00493-9

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

2021

Journal Article

Solitary castrate-resistant prostate cancer metastasis to adrenal gland with concordant intense avidity on PSMA and FDG PET

McGeorge, Stephen, Phillips, Reece, Rukin, Nicholas J., Reynolds, Jamie and Roberts, Matthew J. (2021). Solitary castrate-resistant prostate cancer metastasis to adrenal gland with concordant intense avidity on PSMA and FDG PET. Urology Case Reports, 38 101696, 101696. doi: 10.1016/j.eucr.2021.101696

Solitary castrate-resistant prostate cancer metastasis to adrenal gland with concordant intense avidity on PSMA and FDG PET

2021

Journal Article

Urothelial carcinoma and prostate-specific membrane antigen: cellular, imaging, and prognostic implications

Tariq, Arsalan, McCart Reed, Amy E., Morton, Andrew, Porten, Sima, Vela, Ian, Williams, Elizabeth D., Yaxley, John W., Black, Peter C. and Roberts, Matthew J. (2021). Urothelial carcinoma and prostate-specific membrane antigen: cellular, imaging, and prognostic implications. European Urology Focus, 8 (5), 1256-1269. doi: 10.1016/j.euf.2021.07.016

Urothelial carcinoma and prostate-specific membrane antigen: cellular, imaging, and prognostic implications

2021

Journal Article

Dual-tracer positron-emission tomography using prostate-specific membrane antigen and fluorodeoxyglucose for staging of prostate cancer: a systematic review

McGeorge, Stephen, Kwok, Michael, Jiang, Andrew, Emmett, Louise, Pattison, David A., Thomas, Paul A., Yaxley, John W. and Roberts, Matthew J. (2021). Dual-tracer positron-emission tomography using prostate-specific membrane antigen and fluorodeoxyglucose for staging of prostate cancer: a systematic review. Advances in Urology, 2021 1544208, 1544208. doi: 10.1155/2021/1544208

Dual-tracer positron-emission tomography using prostate-specific membrane antigen and fluorodeoxyglucose for staging of prostate cancer: a systematic review

2021

Journal Article

Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study

Akowuah, Enoch, Benson, Ruth A., Caruana, Edward J., Chetty, Govind, Edwards, John, Forlani, Stefano, Gradinariu, George, Murphy, Gavin J., Oo, Aung Ye, Patel, Akshay J., Ridley, Brenda, Rogers, Luke J., Sanders, Julie, Tyson, Nathan, Vaja, Ricky, Siaw-Acheampong, Kwabena, Argus, Leah, Chaudhry, Daoud, Dawson, Brett E., Glasbey, James C., Gujjuri, Rohan R., Jones, Conor S., Kamarajah, Sivesh K., Khatri, Chetan, Keatley, James M., Lawday, Samuel, Li, Elizabeth, Mann, Harvinder, Marson, Ella J. ... Mazingi, D. (2021). Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study. Journal of Thoracic and Cardiovascular Surgery, 162 (2), e355-e372. doi: 10.1016/j.jtcvs.2021.03.091

Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study

2021

Journal Article

Localised mass-forming amyloidosis of the genitourinary tract mimics urothelial carcinoma: two cases of mistaken identity

Sharma, Pranav, Ajjikuttira, Aiyapa Aruna, Rhee, Handoo, Ashrafi, Darius, Roberts, Matthew John and Chung, Eric (2021). Localised mass-forming amyloidosis of the genitourinary tract mimics urothelial carcinoma: two cases of mistaken identity. Journal of Urological Surgery, 8 (2), 142-144. doi: 10.4274/jus.galenos.2021.0017

Localised mass-forming amyloidosis of the genitourinary tract mimics urothelial carcinoma: two cases of mistaken identity

Funding

Current funding

  • 2024 - 2030
    Prostate Cancer - FDG - Spatial Imaging (Spatial biology meets PET imaging: A non-invasive, Google Map for Prostate cancer)
    PA Research Foundation
    Open grant

Past funding

  • 2022 - 2025
    Randomized, Double-Blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety and Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Path
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2022 - 2023
    Prospective surgeon-led trials in Prostate Cancer for personalised management and healthcare sustainability
    Viertl Clinical Investigator Award
    Open grant
  • 2021 - 2022
    De-Intensification of Post ProstatEctomy Radiotherapy (DIPPER) incorporating clinical and imaging-based risk stratification: Part 1 - Pilot study (additional site)
    ANZUP Below the Belt Research Fund
    Open grant
  • 2021
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study
    Metro North Hospital and Health Service
    Open grant
  • 2021
    Staging of aggressive prostate cancer 'invisible' to PSMA-PET: The FDG-PET for INvisible Disease (FIND) Trial
    Metro North Hospital and Health Service
    Open grant
  • 2018
    Combined TMPRSS2:ERG, PCA3 and SChLAP1 RNA in Urine for selective detection of Aggressive Prostate Cancer
    Metro North Hospital and Health Service
    Open grant
  • 2015
    Exploring new Paradigms in Pre-prostate cancer detection and management
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014 - 2016
    Exploring new Paradigms in Pre-prostate cancer detection and management
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2013
    Optimising collection for metabonomic profiling of ejaculate to complement PCR in prostate cancer detection
    Royal Brisbane and Women's Hospital
    Open grant

Supervision

Availability

Dr Matthew Roberts is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Multi-Bioanalyte Profiling of Metastatic Castration-Resistant Prostate Cancer in a Phase 2 STATEsMAN Trial

    Associate Advisor

    Other advisors: Associate Professor Amy McCart Reed, Dr Kevin M. Koo

  • Doctor Philosophy

    Roles of image fusion and 3D technology in urology: exploration and clinical integration for personalised devices

    Associate Advisor

    Other advisors: Professor Kristofer Thurecht

Media

Enquiries

For media enquiries about Dr Matthew Roberts's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au